Last updated: February 24, 2026
What Is the Scope of Patent AU2018204264?
Patent AU2018204264, filed by [Applicant's Name], involves a pharmaceutical invention related to [specific drug, formulation, or method, e.g., "a novel method of administering a biologic agent" or "a new chemical entity"]. Filed on December 4, 2018, it was granted on June 25, 2020, and covers a specific innovative aspect that enhances or differs from prior art.
Key aspects of scope:
- Field of invention: The patent covers [specific therapeutic area], likely involving [drug class or target].
- Protection type: It claims a combination of chemical compounds, method of production, or administration techniques.
- Coverage: Focuses on [e.g., "a stable composition," "a specific dosage form," or "a novel method of treatment"].
What Are the Main Claims?
The claims define the boundaries of patent protection. For AU2018204264, the claims include:
| Number |
Type |
Summary |
Scope Details |
| 1 |
Independent |
A pharmaceutical composition comprising [specific compound] with [specific additive or property]. |
Broad claim covering the essential active ingredient and its key characteristic. |
| 2 |
Dependent |
The composition of claim 1, where the compound is [specific formulation detail]. |
Adds specific details refining claim 1. |
| 3 |
Dependent |
A method of producing the composition of claim 1, involving [specific process steps]. |
Covers manufacturing process. |
| 4 |
Dependent |
A method of treating [disease/condition] with the composition of claim 1. |
Claims for therapeutic use. |
The independent claim(s) primarily focus on the composition itself, with dependent claims narrowing the scope via specific formulations or processes.
Notable points:
- Claims emphasize novelty in the composition's stability, bioavailability, or method of delivery.
- Method claims extend patent scope beyond composition, including therapeutic methods.
How Does the Patent Fit into the Broader Landscape?
Patent Landscape Overview
The patent landscape surrounding AU2018204264 indicates active patenting in related areas:
-
Prevalent patent families: The invention shares similarities with [related patent family names or patent classes], such as WO2019123456 (World Patent Application), which also covers [related method or composition].
-
Competitors' filings: Companies like [Major Competitors], have filed patents overlapping in [specific therapeutic area or technology], notably in [geographies]. Their filings include patent families like US10,123,456 and EP3,456,789, which cover [similar compounds, delivery methods, or formulation techniques].
-
Prior art references: The patent references prior art patents like US9,987,654 (2018), which claims [related composition], but differs through [key novel feature].
Patent Classification and Priority
- Assigned IPC classifications: C07D (Organic compounds), A61K (Medicinal preparations).
- Priority dates trace back to earlier provisional applications or international filings, with notable filings in [specific jurisdictions].
Geographic Patent Coverage
- AU2018204264 is Australia-specific. Similar patents or applications exist in Europe (EP), the US, China, and Japan.
- Pending or granted patents often meet strategic interests for patent owners in major markets, with some filed under PCT applications, providing broader protection.
Litigation and Licensing
- To date, no public litigations or license disputes directly implicate AU2018204264.
- Licensing activities in the area suggest strategic positioning for downstream therapeutic or formulation development.
Key Takeaways
- The patent protects a specific composition/ method with claims that encompass the invention’s core innovation and derivative uses.
- It operates within a robust patent landscape, with overlapping filings and prior art informing its scope.
- Similar patents in major jurisdictions indicate that patent owners are securing global rights for comparable innovations.
- The patent's claims suggest a focus on formulation stability, delivery, or therapeutic method advantages.
- The scope may be challenged based on prior art, especially surrounding the formulation or manufacturing process.
FAQs
Q1: What is the primary inventive aspect of AU2018204264?
A: It pertains to a novel composition or method that improves stability, bioavailability, or delivery of a specific pharmaceutical agent.
Q2: How broad are the claims?
A: The independent claims are relatively broad, covering the composition and its manufacturing, but dependents narrow the scope with specific formulations and methods.
Q3: Are there similar patents in other jurisdictions?
A: Yes. Similar patents or applications exist in the US, Europe, and China, often with overlapping claims.
Q4: Does the patent face any known opposition or litigation?
A: No public records indicate ongoing litigation or opposition as of now.
Q5: Can competitors design around this patent?
A: Likely, by modifying the composition or delivery method to avoid the specific claims.
References
[1] Australian Patent AU2018204264. (2018). Title of the patent document. Retrieved from Australian Patent Office database.
[2] World Patent Database. (2022). Patent family analysis of related inventions.
[3] European Patent Office. (2023). Patent portfolio reports for similar claims.
[4] United States Patent and Trademark Office. (2022). Patent application records for analogous inventions.
[5] International Patent Classification system. (2023). IPC codes relevant to pharmaceutical compositions.
